Hypomethylating Agent-Based Combination Therapies to Treat Post-Hematopoietic Stem Cell Transplant Relapse of Acute Myeloid Leukemia

Allogeneic stem cell transplantation still represents the best curative option for most patients with acute myeloid leukemia, but relapse is still dramatically high. Due to their immunologic activity and safety profile, hypomethylating agents (HMAs) represent an interesting backbone for combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciotti, Giulia, Marconi, Giovanni, Martinelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770807/
https://www.ncbi.nlm.nih.gov/pubmed/35071015
http://dx.doi.org/10.3389/fonc.2021.810387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770807/
https://www.ncbi.nlm.nih.gov/pubmed/35071015
http://dx.doi.org/10.3389/fonc.2021.810387

Ejemplares similares